These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9216655)

  • 1. A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Kikkawa F; Tamakoshi K; Obata NH; Mizuno K; Suganuma N; Tomoda Y; Kuzuya K; Ishikawa T; Hidaka H
    Anticancer Res; 1997; 17(3C):1985-92. PubMed ID: 9216655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Terasawa M; Ishikawa T; Oguchi H; Mizuno K; Kawai M; Kikkawa F; Tumoda Y; Hidaka H
    Cancer Res; 1993 May; 53(9):2051-6. PubMed ID: 8097673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line.
    Nakanishi Y; Matsuki H; Takayama K; Yatsunami J; Kawasaki M; Abe M; Hara N
    Anticancer Res; 1997; 17(3C):2129-34. PubMed ID: 9216676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloenol lactone: a new synergist of chemotherapy in vitro.
    Zheng J; Wurz GT; Cadman TB; Degregorio MW; Jones AD; Hammock BD
    Biochem Biophys Res Commun; 1997 Dec; 241(1):13-7. PubMed ID: 9405226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glutathione S transferases-pi].
    Takahashi Y; Niitsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
    Byun SS; Kim SW; Choi H; Lee C; Lee E
    BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of KN-62, Ca2+/calmodulin-dependent protein kinase II inhibitor, on adriamycin resistance of human ovarian cancer cells.
    Obata NH; Okazaki K; Maeda O; Kikkawa F; Tomoda Y; Hidaka H
    Biochem Biophys Res Commun; 1995 Oct; 215(2):566-71. PubMed ID: 7487993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
    Ban N; Takahashi Y; Takayama T; Kura T; Katahira T; Sakamaki S; Niitsu Y
    Cancer Res; 1996 Aug; 56(15):3577-82. PubMed ID: 8758929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer].
    Hu YP; Lin J; Wang QD; Yie QX; Zhang TM
    Yao Xue Xue Bao; 1993; 28(1):75-8. PubMed ID: 8328276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of glutathione S-transferase pi in tumor drug resistance].
    Cao W; Zuo J; Fang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):402-6. PubMed ID: 12567441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y; Yoshida O; Miki T; Bonavida B
    Clin Cancer Res; 1999 Sep; 5(9):2605-12. PubMed ID: 10499639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
    Wang X; Kong L; Zhao J; Yang P
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
    Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
    Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.
    Johnstone SA; Gelmon K; Mayer LD; Hancock RE; Bally MB
    Anticancer Drug Des; 2000 Apr; 15(2):151-60. PubMed ID: 10901303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.